|
1
|
He J, Yang L. [Advances in salivary exosomal miRNAs in head and neck squamous carcinoma]. LIN CHUANG ER BI YAN HOU TOU JING WAI KE ZA ZHI = JOURNAL OF CLINICAL OTORHINOLARYNGOLOGY, HEAD, AND NECK SURGERY 2024; 38:261-266. [PMID: 38433699 PMCID: PMC11233219 DOI: 10.13201/j.issn.2096-7993.2024.03.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Indexed: 03/05/2024]
Abstract
Salivary exosomes are extracellular vesicles of 30-150 nm in diameter that exist in saliva and play an important role in substance exchange and signal transduction between cells, delivering the lipids, proteins and nucleic acids they carry to the recipient cells and regulating the physiological and pathological processes of the recipient cells. miRNA, as an important "cargo" in exosomes, is transported to the recipient cells and regulates the signaling pathways of the recipient cells, thus playing a regulatory role in disease progression. The miRNAs are transported to the recipient cells and regulate the signaling pathways of the recipient cells, thus playing a regulatory role in the progression of diseases. With the development of technological tools this year, numerous studies have revealed the important role of salivary exosomal miRNAs in the development of head and neck squamous carcinoma and the role of salivary exosomal miRNAs in the diagnosis and treatment of head and neck squamous carcinoma. This paper reviews the occurrence, treatment and prognosis of salivary exosomal miRNA in head and neck squamous carcinoma, and discusses the potential prospects and importance of salivary exosomal miRNA as a biomarker in the diagnosis of head and neck squamous carcinoma.
Collapse
Affiliation(s)
- Jinyi He
- West China School of Clinical Medicine，Sichuan University，Chengdu，610041，China
| | - Liu Yang
- Department of Otolaryngology Head & Neck Surgery，West China Hospital，Sichuan University
| |
Collapse
|
|
2
|
Liu W, Shi H, Zhou Z, Zhang C, Shen X. Association of salivary miRNAs with onset and progression of oral potentially malignant disorders: Searching for noninvasive biomarkers. J Dent Sci 2023; 18:432-436. [PMID: 36643261 PMCID: PMC9831837 DOI: 10.1016/j.jds.2022.08.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Revised: 07/30/2022] [Indexed: 01/18/2023] Open
Abstract
Background/purpose There is an urgent need for noninvasive biomarkers to diagnose oral potentially malignant disorders (OPMD). A wide range of over 20 miRNAs in saliva of OPMD patients have been investigated in different studies. Yet, which of the ones provide a better power of discrimination for the diagnosis of OPMD onset and progression are uncertain. Materials and methods A total of 17 eligible studies including 426 cases of OPMD and 486 control subjects (352 normal mucosa and 134 oral squamous cell carcinoma) were summarized. Results The bubble chart analysis showed that the most power salivary miRNA associated with OPMD onset was miR-21, followed by miR-31 and miR-142; the better power miRNAs associated with recurrence and malignant progression of OPMD were miR-31, miR-21, and miR-184. Conclusion Salivary miRNAs, especially miR-21 and miR-31, were associated with onset and progression of OPMD, and could then serve as noninvasive biomarkers for screening OPMD and detecting malignant changes.
Collapse
Affiliation(s)
- Wei Liu
- Department of Stomatology, Fengcheng Hospital of Fengxian District, Shanghai Ninth People's Hospital Fengcheng Branch Hospital, Shanghai, China
- College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China
- Department of Oral and Maxillofacial–Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Huan Shi
- College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China
- Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Zengtong Zhou
- College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China
- Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Chenping Zhang
- College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China
- Department of Oral and Maxillofacial–Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Corresponding author. Department of Oral and Maxillofacial–Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
| | - Xuemin Shen
- College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China
- Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Corresponding author. Department of Oral Mucosal Diseases, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
| |
Collapse
|